Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 0 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NRX Pharmaceuticals Inc | NRXPW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 0,0026 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,0026 |
| Trades | Volumen | Durchsch. Volumen |
|---|---|---|
| 0 | 0 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| - | 0 | 0,0026 | USD |
Finanzwerte NRXPW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 94,20k | - | - | - | -0,00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NRX Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 02.6.2026 | 23:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02.6.2026 | 23:28 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 15.5.2026 | 22:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 24.3.2026 | 21:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 23.3.2026 | 21:30 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 24.2.2026 | 23:00 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
| 23.2.2026 | 23:15 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 23.2.2026 | 23:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 17.2.2026 | 15:21 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.2.2026 | 15:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.2.2026 | 15:20 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 13.2.2026 | 22:31 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
Forum NRX Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NRXPW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:NRXPW -
What is the current NRX Pharmaceuticals Inc share price?
The current share price of NRX Pharmaceuticals Inc is US$ 0,0026
What is the 1 year trading range for NRX Pharmaceuticals Inc share price?
NRX Pharmaceuticals Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
